NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CC Diagnostics

CC Diagnostics

Private
GroningenHealthcare & Life Scienceshttps://cc-diagnostics.com/

Last Round

Grant

Sep 23, 2025

Total Funding Raised

$648,000

Company Overview

CC Diagnostics is a biotechnology company that develops PCR-based diagnostic solutions for the early detection of cervical cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

cervical cancer screeningmolecular diagnosticsepigenetic DNA analysisqPCRDNA methylationdiagnostic assayliquid-based cytologyself-samplingcancer triageclinical laboratorybiomarkerliquid biopsyhome testingpathologymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CC Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CC Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CC Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 23, 2025
AcceleratorMay 13, 2024
GrantMay 1, 2023
SeedJul 17, 2018
DebtJul 17, 2018

Key People

Founding team and executive leadership

Nutte van Belzen

Co-founder & Chief Medical Officer

Founding Team

Ronald Vos

Chief Executive Officer

Executive Team

CC Diagnostics Investors

Notable investors and investment history

CC Diagnostics investors
InvestorRounds
Carduso CapitalSeed
Tech4EvaAccelerator
Samenwerkingsverband Noord-NederlandGrant
Netherlands Enterprise AgencyDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 16, 2023

    Grew 133% QoQ from 3 to 7 employees.

CC Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CC Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CC Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGroningen
Employee Range10
Year Founded2016
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.